welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!
recruiting

Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy

key information

study id #: NCT03067831

condition: Duchenne Muscular Dystrophy

status: recruiting

purpose:

This study is single arm, single center trial to study the safety and efficacy of bone marrow-derived autologous specific populations of stem cells and mesenchymal stem cells for the treatment of Duchenne Muscular Dystrophy (DMD).

intervention: Stem Cells

mechanism of action: Stem cell therapy to promote cellular regeneration

results: https://clinicaltrials.gov/ct2/show/results/NCT03067831

last updated: November 18, 2019

rareRelated